Your local office
We are looking for the closest office..

CFI advised Bioforce AG, Switzerland, in the acquisition of the shares it did not already own in the joint venture with Bioforce Denmark A/S, Denmark

Zurich – CFI Switzerland is pleased to announce that they supported Bioforce AG, Switzerland in the acquisition of the shares it did not already own in the joint venture with Bioforce Denmark A/S, Denmark. Prior to closing the transaction, Bioforce AG had a minority interest in Bioforce Denmark A/S.

Bioforce AG develops and produces phytopharmaceuticals, nutraceuticals and food supplements for international distribution. Besides its products, the philosophy of Bioforce is to focus on comprehensive and well-founded information on health topics. Bioforce has 350 employees and generates sales of approx. CHF 110 m.

Bioforce Denmark A/S is the exclusive distributor of Bioforce products in Denmark. The company is run by the founder and owner.

The parties agreed not to disclose further transaction details.

The transaction closed on 1 January 2019.

 

Healthcare & Life Sciences

acquired the shares it did not already own in

Advised by:

Malte Jantz

Similar Transactions

Healthcare & Life Sciences

has made a collection of Euro 50 million in form of Acquistion Financing

Transaction details

CEF, a leading italian wholesale distirbutor of pharmaceuticals products to Italian pharmacies, has made a collection of Euro 50 million in form of Acquistion Financing.

BPO

has been sold to

Transaction details

Careflex Zorg Groep, the largest independent external healthcare provider for complex care with a proven and distinct BPO proposition in the Benelux, has been sold to Bolster Investment Partners

Healthcare & Life Sciences

acquired a majority stake in

from

Transaction details

Ergon Capital Partners has acquired a majority stake in Indo Optical, a leading Spanish independent manufacturer of ophtalmic lenses and distributor of optical and ophtalmologic equipment

Healthcare & Life Sciences

a portfolio company of

has been acquired by

Transaction details

Royal Philips, a global leader in sleep and respiratory care, acquires RespirTech, a portfolio company of Whitecliff Capital Partners which manufactures the inCourage® System, an innovative airway clearance solution for patients with chronic respiratory conditions